AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $666,000 | +27.3% | 70,872 | +3.7% | 0.00% | 0.0% |
| Q2 2020 | $523,000 | +23.3% | 68,372 | -0.3% | 0.00% | 0.0% |
| Q1 2020 | $424,000 | -52.5% | 68,600 | -6.4% | 0.00% | 0.0% |
| Q4 2019 | $892,000 | -3.9% | 73,300 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $928,000 | +29.2% | 80,327 | +11.8% | 0.00% | 0.0% |
| Q2 2019 | $718,000 | -32.5% | 71,853 | -13.0% | 0.00% | 0.0% |
| Q1 2019 | $1,064,000 | -19.5% | 82,584 | -5.1% | 0.00% | -50.0% |
| Q4 2018 | $1,321,000 | -23.5% | 86,987 | +0.8% | 0.00% | 0.0% |
| Q3 2018 | $1,726,000 | -1.9% | 86,297 | -4.4% | 0.00% | 0.0% |
| Q2 2018 | $1,760,000 | -9.3% | 90,252 | -6.3% | 0.00% | -33.3% |
| Q1 2018 | $1,941,000 | +73.9% | 96,339 | +14.4% | 0.00% | +50.0% |
| Q4 2017 | $1,116,000 | -28.2% | 84,241 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,554,000 | +2.0% | 84,241 | +1.7% | 0.00% | 0.0% |
| Q2 2017 | $1,524,000 | -16.6% | 82,800 | +2.2% | 0.00% | -33.3% |
| Q1 2017 | $1,827,000 | -37.9% | 81,000 | -4.1% | 0.00% | -40.0% |
| Q4 2016 | $2,941,000 | +35.1% | 84,500 | -4.8% | 0.01% | +25.0% |
| Q3 2016 | $2,177,000 | -4.3% | 88,800 | -6.6% | 0.00% | 0.0% |
| Q2 2016 | $2,275,000 | -0.9% | 95,100 | -3.1% | 0.00% | 0.0% |
| Q1 2016 | $2,296,000 | -26.9% | 98,100 | -5.7% | 0.00% | -20.0% |
| Q4 2015 | $3,140,000 | -47.7% | 104,000 | -31.1% | 0.01% | -50.0% |
| Q3 2015 | $5,999,000 | -41.0% | 151,000 | +2.6% | 0.01% | -33.3% |
| Q2 2015 | $10,166,000 | +109.4% | 147,200 | +34.4% | 0.02% | +114.3% |
| Q1 2015 | $4,855,000 | 0.0% | 109,500 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $4,855,000 | +92.6% | 109,500 | +38.6% | 0.01% | +133.3% |
| Q3 2014 | $2,521,000 | +54.0% | 79,000 | 0.0% | 0.00% | +50.0% |
| Q2 2014 | $1,637,000 | +15.1% | 79,000 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $1,422,000 | -24.8% | 79,000 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $1,890,000 | +10.1% | 79,000 | -1.2% | 0.00% | 0.0% |
| Q3 2013 | $1,717,000 | -10.0% | 79,954 | -6.8% | 0.00% | -25.0% |
| Q2 2013 | $1,908,000 | – | 85,754 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
| Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
| Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
| Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
| Fondren Management LP | 35,000 | $404,000 | 0.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
| BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
| Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
| FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
| Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |